Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Brian VanderBeek, MD, MPH

Brian VanderBeek, MD, MPH

faculty photo
Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania
Department: Ophthalmology

Contact information
Scheie Eye Institute
51 N. 39th Street
Philadelphia, PA 19104
Education:
B.A. (Biology)
University of Michigan, School of Literature, Science & Arts, 1999.
M.P.H (Toxicology)
University of Michigan, School of Public Health, 2001.
M.D.
University of Cincinnati College of Medicine, 2005.
MSCE
University of Pennsylvania School of Medicine, 2015.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

VanderBeek BL, Bonaffini SG, Ma L : The impact of intravitreal drugs on rates of post-injection endophthalmitis. International Conference on Pharmacoepidemiology, Boston, MA Aug 2015 Notes: Poster presentation.

VanderBeek Brian L, Bonaffini Sarah G, Ma Liyuan: Association of Compounded Bevacizumab With Postinjection Endophthalmitis. JAMA ophthalmology Aug 2015 Notes: Epub ahead of print.

VanderBeek Brian L, Bonaffini Sarah G, Ma Liyuan: The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates. Ophthalmology Aug 2015 Notes: Epub ahead of print.

VanderBeek Brian L: Re: Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade. Retina (Philadelphia, Pa.) 35(7): e40-2, Jul 2015.

Bonaffini SG, VanderBeek BL: The changing rate of post intravitreal injection endophthalmitis: a 10-year study of a large U.S. national insurance database. Association for Research in Vision and Ophthalmology Annual Meeting, Denver, CO May 2015 Notes: Poster presentation.

Bressler Susan B, Almukhtar Talat, Bhorade Anjali, Bressler Neil M, Glassman Adam R, Huang Suber S, Jampol Lee M, Kim Judy E, Melia Michele: Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. JAMA ophthalmology 133(5): 589-97, May 2015.

Wells John A, Glassman Adam R, Ayala Allison R, Jampol Lee M, Aiello Lloyd Paul, Antoszyk Andrew N, Arnold-Bush Bambi, Baker Carl W, Bressler Neil M, Browning David J, Elman Michael J, Ferris Frederick L, Friedman Scott M, Melia Michele, Pieramici Dante J, Sun Jennifer K, Beck Roy W: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. The New England journal of medicine 372(13): 1193-203, Mar 2015.

VanderBeek BL, Lee V: Geographic Atrophy: A Histopathologic Assessment. Year Book of Ophthalmology 2015. Elseveir Publishing, Philadelphia, PA 2015.

Ghodasra Devon H, Eftekhari Kian, Shah Ankoor R, VanderBeek Brian L: Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting. Ophthalmology 121(12): 2334-9, Dec 2014.

Eftekhari Kian, Ghodasra Devon H, Haynes Kevin, Chen Jinbo, Kempen John H, VanderBeek Brian L: Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiology and drug safety 23(7): 745-52, Jul 2014.

back to top
Last updated: 08/28/2015
The Trustees of the University of Pennsylvania